Related references
Note: Only part of the references are listed.Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer's Disease
Ankit Jana et al.
MOLECULAR NEUROBIOLOGY (2022)
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro et al.
PHARMACEUTICALS (2022)
Impact of the Flavonoid Quercetin on β-Amyloid Aggregation Revealed by Intrinsic Fluorescence
Abeer Alghamdi et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2022)
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
Gabriella Marucci et al.
NEUROPHARMACOLOGY (2021)
Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation
Joanna Kowalczyk et al.
BIOMACROMOLECULES (2021)
Unraveling the Speciation of β-Amyloid Peptides during the Aggregation Process by Taylor Dispersion Analysis
Mihai Deleanu et al.
ANALYTICAL CHEMISTRY (2021)
2021 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2021)
The biological pathways of Alzheimer disease: a review
Marco Calabro et al.
AIMS NEUROSCIENCE (2021)
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
F. Javier Perez-Areales et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease
Vinay Kumar et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Peak Fitting Applied to Fourier Transform Infrared and Raman Spectroscopic Analysis of Proteins
Azin Sadat et al.
APPLIED SCIENCES-BASEL (2020)
Multiple reactivities of flavonoids towards pathological elements in Alzheimer's disease: structure-activity relationship
Geewoo Nam et al.
CHEMICAL SCIENCE (2020)
Aryldiazoquinoline based multifunctional small molecules for modulating Aβ42aggregation and cholinesterase activity related to Alzheimer's disease
Monika Rana et al.
RSC ADVANCES (2020)
Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases
Alba Espargaro et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
Haroon Khan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Computational Study of the Aza-Michael Addition of the Flavonoid (+)-Taxifolin in the Inhibition of β-Amyloid Fibril Aggregation
Tiziana Ginex et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Alzheimer's disease hypothesis and related therapies
Xiaoguang Du et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs
Alba Espargaro et al.
JOURNAL OF NATURAL PRODUCTS (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach
Elena Simoni et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology
Gang Wei et al.
CHEMICAL SOCIETY REVIEWS (2017)
β-amyloid-acetylcholine molecular interaction: new role of cholinergic mediators in anti-Alzheimer therapy?
Manuela Grimaldi et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease
Federica Prati et al.
MOLECULES (2016)
Functions of flavonoids in the central nervous system: Astrocytes as targets for natural compounds
Isadora Matias et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
Alba Espargaro et al.
SCIENTIFIC REPORTS (2016)
Flavonoids: an overview
A. N. Panche et al.
JOURNAL OF NUTRITIONAL SCIENCE (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Inhibition of flavonoids on acetylcholine esterase: binding and structure-activity relationship
Yixi Xie et al.
FOOD & FUNCTION (2014)
A review on cholinesterase inhibitors for Alzheimer's disease
Preet Anand et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Colovic et al.
CURRENT NEUROPHARMACOLOGY (2013)
Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues
Mizuho Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
High Correlation of 2,2-diphenyl-1-picrylhydrazyl (DPPH) Radical Scavenging, Ferric Reducing Activity Potential and Total Phenolics Content Indicates Redundancy in Use of All Three Assays to Screen for Antioxidant Activity of Extracts of Plants from the Malaysian Rainforest
Garry Clarke et al.
ANTIOXIDANTS (2013)
The Amyloid Beta Peptide: A Chemist's Perspective. Role in Alzheimer's and Fibrillization
I. W. Hamley
CHEMICAL REVIEWS (2012)
Determination of acetylcholinesterase activity by the Ellman assay: A versatile tool for in vitro research on medical countermeasures against organophosphate poisoning
Franz Worek et al.
DRUG TESTING AND ANALYSIS (2012)
Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases
Caries Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Epidemiology of Alzheimer disease
Christiane Reitz et al.
NATURE REVIEWS NEUROLOGY (2011)
Interactions of AChE with A beta aggregates in Alzheimer's brain: therapeutic relevance of IDN 5706
Francisco J. Carvajal et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Acetylcholinesterase: From 3D structure to function
Hay Dvir et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Roland Jakob-Roetne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds
Pelayo Camps et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Amyloid-cholinesterase interactions - Implications for Alzheimer's disease
Nibaldo C. Inestrosa et al.
FEBS JOURNAL (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: Evidence for multiple steps and lateral association coupled to conformational conversion
Santosh Kumar et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Cholinesterase inhibitors used in the treatment of Alzheimer's disease the relationship between pharmacological effects and clinical efficacy
DG Wilkinson et al.
DRUGS & AGING (2004)
An autocatalytic reaction, as a model for the kinetics of the aggregation of beta-amyloid
R Sabate et al.
BIOPOLYMERS (2003)
A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation
GV De Ferrari et al.
BIOCHEMISTRY (2001)
Share Paper
